Selected research
Industry Research
AI Drug Discovery Industry Research Report 2026
Market perspective
The global AI Drug Discovery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Drug Discovery market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Drug Discovery market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Drug Discovery market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Drug Discovery include Recursion, Insilico Medicine, Schrödinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics and BenevolentAI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Drug Discovery market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Drug Discovery.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Drug Discovery Market by Company
Recursion
Insilico Medicine
Schrödinger
DeepMind
Insitro
Generate Biomedicines
XtalPi
Relay Therapeutics
BenevolentAI
Roivant Sciences
Ginkgo Bioworks
Exscientia
Merck KGaA
Novartis
Biotus
Huazhi Bio
MindRank AI
Ubigene
WuXi AppTec
AI Drug Discovery Segment by Type
Machine Learning Type
Deep Learning Type
Natural Language Processing Type
Data Mining Type
AI Drug Discovery Segment by Application
Target Discovery and Validation
Virtual Screening and Molecular Docking
Drug Repurposing and Precision Medicine
Clinical Data Analysis and Optimization
AI Drug Discovery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Machine Learning Type
- Deep Learning Type
- Natural Language Processing Type
- Data Mining Type
Applications
- Target Discovery and Validation
- Virtual Screening and Molecular Docking
- Drug Repurposing and Precision Medicine
- Clinical Data Analysis and Optimization
Companies covered
- Recursion
- Insilico Medicine
- Schrödinger
- DeepMind
- Insitro
- Generate Biomedicines
- XtalPi
- Relay Therapeutics
- BenevolentAI
- Roivant Sciences
- Ginkgo Bioworks
- Exscientia
- Merck KGaA
- Novartis
- Biotus
- Huazhi Bio
- MindRank AI
- Ubigene
- WuXi AppTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Drug Discovery by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Machine Learning Type
- 2.2.3 Deep Learning Type
- 2.2.4 Natural Language Processing Type
- 2.2.5 Data Mining Type
- 2.3 AI Drug Discovery by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Target Discovery and Validation
- 2.3.3 Virtual Screening and Molecular Docking
- 2.3.4 Drug Repurposing and Precision Medicine
- 2.3.5 Clinical Data Analysis and Optimization
- 2.4 Assumptions and Limitations
3 AI Drug Discovery Breakdown Data by Type
- 3.1 Global AI Drug Discovery Historic Market Size by Type (2021-2026)
- 3.2 Global AI Drug Discovery Forecasted Market Size by Type (2027-2032)
4 AI Drug Discovery Breakdown Data by Application
- 4.1 Global AI Drug Discovery Historic Market Size by Application (2021-2026)
- 4.2 Global AI Drug Discovery Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Drug Discovery Market Perspective (2021-2032)
- 5.2 Global AI Drug Discovery Growth Trends by Region
- 5.2.1 Global AI Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Drug Discovery Historic Market Size by Region (2021-2026)
- 5.2.3 AI Drug Discovery Forecasted Market Size by Region (2027-2032)
- 5.3 AI Drug Discovery Market Dynamics
- 5.3.1 AI Drug Discovery Industry Trends
- 5.3.2 AI Drug Discovery Market Drivers
- 5.3.3 AI Drug Discovery Market Challenges
- 5.3.4 AI Drug Discovery Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Drug Discovery Players by Revenue
- 6.1.1 Global Top AI Drug Discovery Players by Revenue (2021-2026)
- 6.1.2 Global AI Drug Discovery Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Drug Discovery Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Drug Discovery Head Office and Area Served
- 6.4 Global AI Drug Discovery Players, Product Type & Application
- 6.5 Global AI Drug Discovery Manufacturers Established Date
- 6.6 Global AI Drug Discovery Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Drug Discovery Market Size (2021-2032)
- 7.2 North America AI Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Drug Discovery Market Size by Country (2021-2026)
- 7.4 North America AI Drug Discovery Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Drug Discovery Market Size (2021-2032)
- 8.2 Europe AI Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Drug Discovery Market Size by Country (2021-2026)
- 8.4 Europe AI Drug Discovery Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Discovery Market Size (2021-2032)
- 9.2 Asia-Pacific AI Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Drug Discovery Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Drug Discovery Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Drug Discovery Market Size (2021-2032)
- 10.2 South America AI Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Drug Discovery Market Size by Country (2021-2026)
- 10.4 South America AI Drug Discovery Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Discovery Market Size (2021-2032)
- 11.2 Middle East & Africa AI Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Drug Discovery Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Drug Discovery Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Recursion
- 12.1.1 Recursion Company Information
- 12.1.2 Recursion Business Overview
- 12.1.3 Recursion Revenue in AI Drug Discovery Business (2021-2026)
- 12.1.4 Recursion AI Drug Discovery Product Portfolio
- 12.1.5 Recursion Recent Developments
- 12.2 Insilico Medicine
- 12.2.1 Insilico Medicine Company Information
- 12.2.2 Insilico Medicine Business Overview
- 12.2.3 Insilico Medicine Revenue in AI Drug Discovery Business (2021-2026)
- 12.2.4 Insilico Medicine AI Drug Discovery Product Portfolio
- 12.2.5 Insilico Medicine Recent Developments
- 12.3 Schrödinger
- 12.3.1 Schrödinger Company Information
- 12.3.2 Schrödinger Business Overview
- 12.3.3 Schrödinger Revenue in AI Drug Discovery Business (2021-2026)
- 12.3.4 Schrödinger AI Drug Discovery Product Portfolio
- 12.3.5 Schrödinger Recent Developments
- 12.4 DeepMind
- 12.4.1 DeepMind Company Information
- 12.4.2 DeepMind Business Overview
- 12.4.3 DeepMind Revenue in AI Drug Discovery Business (2021-2026)
- 12.4.4 DeepMind AI Drug Discovery Product Portfolio
- 12.4.5 DeepMind Recent Developments
- 12.5 Insitro
- 12.5.1 Insitro Company Information
- 12.5.2 Insitro Business Overview
- 12.5.3 Insitro Revenue in AI Drug Discovery Business (2021-2026)
- 12.5.4 Insitro AI Drug Discovery Product Portfolio
- 12.5.5 Insitro Recent Developments
- 12.6 Generate Biomedicines
- 12.6.1 Generate Biomedicines Company Information
- 12.6.2 Generate Biomedicines Business Overview
- 12.6.3 Generate Biomedicines Revenue in AI Drug Discovery Business (2021-2026)
- 12.6.4 Generate Biomedicines AI Drug Discovery Product Portfolio
- 12.6.5 Generate Biomedicines Recent Developments
- 12.7 XtalPi
- 12.7.1 XtalPi Company Information
- 12.7.2 XtalPi Business Overview
- 12.7.3 XtalPi Revenue in AI Drug Discovery Business (2021-2026)
- 12.7.4 XtalPi AI Drug Discovery Product Portfolio
- 12.7.5 XtalPi Recent Developments
- 12.8 Relay Therapeutics
- 12.8.1 Relay Therapeutics Company Information
- 12.8.2 Relay Therapeutics Business Overview
- 12.8.3 Relay Therapeutics Revenue in AI Drug Discovery Business (2021-2026)
- 12.8.4 Relay Therapeutics AI Drug Discovery Product Portfolio
- 12.8.5 Relay Therapeutics Recent Developments
- 12.9 BenevolentAI
- 12.9.1 BenevolentAI Company Information
- 12.9.2 BenevolentAI Business Overview
- 12.9.3 BenevolentAI Revenue in AI Drug Discovery Business (2021-2026)
- 12.9.4 BenevolentAI AI Drug Discovery Product Portfolio
- 12.9.5 BenevolentAI Recent Developments
- 12.10 Roivant Sciences
- 12.10.1 Roivant Sciences Company Information
- 12.10.2 Roivant Sciences Business Overview
- 12.10.3 Roivant Sciences Revenue in AI Drug Discovery Business (2021-2026)
- 12.10.4 Roivant Sciences AI Drug Discovery Product Portfolio
- 12.10.5 Roivant Sciences Recent Developments
- 12.11 Ginkgo Bioworks
- 12.11.1 Ginkgo Bioworks Company Information
- 12.11.2 Ginkgo Bioworks Business Overview
- 12.11.3 Ginkgo Bioworks Revenue in AI Drug Discovery Business (2021-2026)
- 12.11.4 Ginkgo Bioworks AI Drug Discovery Product Portfolio
- 12.11.5 Ginkgo Bioworks Recent Developments
- 12.12 Exscientia
- 12.12.1 Exscientia Company Information
- 12.12.2 Exscientia Business Overview
- 12.12.3 Exscientia Revenue in AI Drug Discovery Business (2021-2026)
- 12.12.4 Exscientia AI Drug Discovery Product Portfolio
- 12.12.5 Exscientia Recent Developments
- 12.13 Merck KGaA
- 12.13.1 Merck KGaA Company Information
- 12.13.2 Merck KGaA Business Overview
- 12.13.3 Merck KGaA Revenue in AI Drug Discovery Business (2021-2026)
- 12.13.4 Merck KGaA AI Drug Discovery Product Portfolio
- 12.13.5 Merck KGaA Recent Developments
- 12.14 Novartis
- 12.14.1 Novartis Company Information
- 12.14.2 Novartis Business Overview
- 12.14.3 Novartis Revenue in AI Drug Discovery Business (2021-2026)
- 12.14.4 Novartis AI Drug Discovery Product Portfolio
- 12.14.5 Novartis Recent Developments
- 12.15 Biotus
- 12.15.1 Biotus Company Information
- 12.15.2 Biotus Business Overview
- 12.15.3 Biotus Revenue in AI Drug Discovery Business (2021-2026)
- 12.15.4 Biotus AI Drug Discovery Product Portfolio
- 12.15.5 Biotus Recent Developments
- 12.16 Huazhi Bio
- 12.16.1 Huazhi Bio Company Information
- 12.16.2 Huazhi Bio Business Overview
- 12.16.3 Huazhi Bio Revenue in AI Drug Discovery Business (2021-2026)
- 12.16.4 Huazhi Bio AI Drug Discovery Product Portfolio
- 12.16.5 Huazhi Bio Recent Developments
- 12.17 MindRank AI
- 12.17.1 MindRank AI Company Information
- 12.17.2 MindRank AI Business Overview
- 12.17.3 MindRank AI Revenue in AI Drug Discovery Business (2021-2026)
- 12.17.4 MindRank AI AI Drug Discovery Product Portfolio
- 12.17.5 MindRank AI Recent Developments
- 12.18 Ubigene
- 12.18.1 Ubigene Company Information
- 12.18.2 Ubigene Business Overview
- 12.18.3 Ubigene Revenue in AI Drug Discovery Business (2021-2026)
- 12.18.4 Ubigene AI Drug Discovery Product Portfolio
- 12.18.5 Ubigene Recent Developments
- 12.19 WuXi AppTec
- 12.19.1 WuXi AppTec Company Information
- 12.19.2 WuXi AppTec Business Overview
- 12.19.3 WuXi AppTec Revenue in AI Drug Discovery Business (2021-2026)
- 12.19.4 WuXi AppTec AI Drug Discovery Product Portfolio
- 12.19.5 WuXi AppTec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst